{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:45:14Z","timestamp":1792233914733,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-026-00950-y","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:08:10Z","timestamp":1792231690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR\u2011660\u20115p ameliorates neuronal damage in Alzheimer\u2019s disease via targeting APP"],"prefix":"10.1007","volume":"27","author":[{"given":"Pingting","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yika","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"950_CR1","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham PT, Shukla R, Khatri DK, Vora LK (2024) Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier. Ageing Res Rev 101:102481","journal-title":"Ageing Res Rev"},{"issue":"1","key":"950_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/0118744710314668240718070109","volume":"18","author":"F Aghahosseini","year":"2024","unstructured":"Aghahosseini F, Salehi Y, Farzanefar S, Bakhshi Kashi M, Eppard E, Ahmadzadehfar H et al (2024) Recent advances in the diagnosis of Alzheimer\u2019s disease: A brief overview of Tau PET tracers in nuclear medicine. Curr Radiopharmaceuticals 18(1):23\u201336","journal-title":"Curr Radiopharmaceuticals"},{"issue":"6","key":"950_CR3","first-page":"893","volume":"21","author":"OO Babalola","year":"2024","unstructured":"Babalola OO, Ottu PO, Akinola OA, Kehinde IO, Oluwatobiloba AF, Oluwamodupe C et al (2024) Computational evaluation of bioactive compounds from bryophyllum pinnatum as a novel GSK3B inhibitor in Alzheimer\u2019s disease. J Alzheimers Dis 21(6):893\u2013903","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"950_CR4","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.lddd.2025.100260","volume":"22","author":"AP Sivaperuman","year":"2025","unstructured":"Sivaperuman AP, Natarajan A, Calambur Nagarajan R, Nachiappan N, Solomon DM VR (2025) Computational investigation and synthesis of 6-chlorocoumarin-oxadiazole hybrids for identifying newer candidates against Alzheimer\u2019s disease using multi-target strategies. Lett Drug Des Discovery 22(11):100260","journal-title":"Lett Drug Des Discovery"},{"issue":"1","key":"950_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40035-026-00537-5","volume":"15","author":"J Zhou","year":"2026","unstructured":"Zhou J, Zhang X, Yin S, Xue S, He Q, Chen S et al (2026) Molecular mechanisms of exercise-induced improvements in Alzheimer\u2019s disease: a focus on lipid homeostasis. Transl Neurodegener 15(1):11","journal-title":"Transl Neurodegener"},{"issue":"11","key":"950_CR6","doi-asserted-by":"publisher","first-page":"100263","DOI":"10.1016\/j.lddd.2025.100263","volume":"22","author":"A Madeswaran","year":"2025","unstructured":"Madeswaran A, Lemathi C (2025) Unwinding the complexities of diabetic Alzheimer using myricetin and naringenin in streptozocin-nicotinamide-induced rat model. Lett Drug Des Discov 22(11):100263","journal-title":"Lett Drug Des Discov"},{"issue":"4","key":"950_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3233\/JAD-220116","volume":"88","author":"SY Chia","year":"2022","unstructured":"Chia SY, Vipin A, Ng KP, Tu H, Bommakanti A, Wang BZ et al (2022) Upregulated Blood miR-150-5p in Alzheimer\u2019s Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-\u03b2, and Cerebral Atrophy. J Alzheimer\u2019s disease: JAD 88(4):1567\u20131584","journal-title":"J Alzheimer\u2019s disease: JAD"},{"issue":"16","key":"950_CR8","doi-asserted-by":"publisher","first-page":"169046","DOI":"10.1016\/j.jmb.2025.169046","volume":"437","author":"IE Bowles","year":"2025","unstructured":"Bowles IE, Orellana EA, Rethinking RNA, Modifications (2025) Therapeutic Strategies for Targeting Dysregulated RNA. J Mol Biol 437(16):169046","journal-title":"J Mol Biol"},{"issue":"18","key":"950_CR9","doi-asserted-by":"publisher","first-page":"126561","DOI":"10.3390\/ijms25189936","volume":"25","author":"N Puranik","year":"2024","unstructured":"Puranik N, Song M (2024) Insights into the role of microRNAs as clinical tools for diagnosis, prognosis, and as therapeutic targets in Alzheimer\u2019s disease. Int J Mol Sci 25(18):126561","journal-title":"Int J Mol Sci"},{"issue":"s1","key":"950_CR10","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.3233\/JAD-190583","volume":"72","author":"S Kumar","year":"2019","unstructured":"Kumar S, Reddy PH (2019) A New Discovery of MicroRNA-455-3p in Alzheimer\u2019s Disease. J Alzheimer\u2019s disease: JAD 72(s1):S117\u2013s30","journal-title":"J Alzheimer\u2019s disease: JAD"},{"issue":"1","key":"950_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-023-01366-8","volume":"16","author":"SW Han","year":"2024","unstructured":"Han SW, Pyun JM, Bice PJ, Bennett DA, Saykin AJ, Kim SY et al (2024) miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer\u2019s disease. Alzheimers Res Ther 16(1):5","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"950_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13195-025-01834-3","volume":"17","author":"J Choi","year":"2025","unstructured":"Choi J, Kim D, Jeong H, Hwang J, Ramalingam M, Han S et al (2025) A novel miR-4536-3p inhibition ameliorates Alzheimer\u2019s disease by reducing A\u03b2 accumulation and tau phosphorylation. Alzheimers Res Ther 17(1):189","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"950_CR13","doi-asserted-by":"publisher","first-page":"e70572","DOI":"10.1002\/brb3.70572","volume":"15","author":"P Saberian","year":"2025","unstructured":"Saberian P, Darvishi A, Khezragha D, Forouzandegan M, Farhadieh ME, Taghizadeh Khorshidi S et al (2025) MicroRNA Signatures Predict Brain Amyloidosis and Neurodegeneration in Alzheimer\u2019s Disease: Insights from [(18)F] AV45 and FDG PET Imaging. Brain Behav 15(5):e70572","journal-title":"Brain Behav"},{"key":"950_CR14","doi-asserted-by":"crossref","unstructured":"Satoh J, Kino Y, Niida S (2015) Biomark insights 10:21\u201331MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer\u2019s Disease from Public Data","DOI":"10.4137\/BMI.S25132"},{"issue":"7","key":"950_CR15","doi-asserted-by":"publisher","first-page":"e70526","DOI":"10.1111\/jnc.70526","volume":"170","author":"GV Jauregui","year":"2026","unstructured":"Jauregui GV, Coomes S, Emmett E, Thatcher A, Oyelakin N, \u010carna M et al (2026) APP\/A\u03b2 Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer\u2019s Disease. J Neurochem 170(7):e70526","journal-title":"J Neurochem"},{"issue":"10","key":"950_CR16","doi-asserted-by":"publisher","first-page":"12722","DOI":"10.1007\/s12035-025-05082-2","volume":"62","author":"H Eciroglu-Sarban","year":"2025","unstructured":"Eciroglu-Sarban H, Altin-Celik P, Kelicen-Ugur P, Donmez-Altuntas H (2025) Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on A\u03b2(1\u201342)-Induced Neurotoxicity in Differentiated SH-SY5Y Cells. Mol Neurobiol 62(10):12722\u201312735","journal-title":"Mol Neurobiol"},{"issue":"11","key":"950_CR17","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1039\/D3MD00308F","volume":"14","author":"N Gouleni","year":"2023","unstructured":"Gouleni N, Di Rienzo A, Y\u0131lmaz A, Selvitopi H, Arslan ME, Mardinoglu A et al (2023) Novel styryl-thiazole hybrids as potential anti-Alzheimer\u2019s agents. RSC Med Chem 14(11):2315\u20132326","journal-title":"RSC Med Chem"},{"issue":"2","key":"950_CR18","doi-asserted-by":"publisher","first-page":"e14546","DOI":"10.1002\/alz.14546","volume":"21","author":"AS Zannas","year":"2025","unstructured":"Zannas AS (2025) Circulating small RNAs shed new light on dementia risk. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 21(2):e14546","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"8","key":"950_CR19","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.tjpad.2025.100257","volume":"12","author":"T Sikosek","year":"2025","unstructured":"Sikosek T, Heuvelman M, Mika J, Kahraman M, Jehn J, Frank M et al (2025) Early detection of Alzheimer\u2019s disease using small RNAs. Results from the EPAD cohort. J Prev Alzheimer\u2019s disease 12(8):100257","journal-title":"J Prev Alzheimer\u2019s disease"},{"issue":"1","key":"950_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/13872877241313397","volume":"104","author":"J Ramirez-Gomez","year":"2025","unstructured":"Ramirez-Gomez J, Dalal S, Devara D, Sharma B, Rodarte D, Kumar S (2025) MicroRNA-based recent research developments in Alzheimer\u2019s disease. J Alzheimer\u2019s disease: JAD 104(1):14\u201331","journal-title":"J Alzheimer\u2019s disease: JAD"},{"issue":"5","key":"950_CR21","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s11010-024-05164-0","volume":"480","author":"W Liu","year":"2025","unstructured":"Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J et al (2025) The neuroinflammatory role of microRNAs in Alzheimer\u2019s disease: pathological insights to therapeutic potential. Mol Cell Biochem 480(5):2689\u20132706","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"950_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12974-022-02548-1","volume":"19","author":"P Xia","year":"2022","unstructured":"Xia P, Chen J, Liu Y, Cui X, Wang C, Zong S et al (2022) MicroRNA-22-3p ameliorates Alzheimer\u2019s disease by targeting SOX9 through the NF-\u03baB signaling pathway in the hippocampus. J Neuroinflamm 19(1):180","journal-title":"J Neuroinflamm"},{"key":"950_CR23","doi-asserted-by":"publisher","first-page":"103149","DOI":"10.1016\/j.scr.2023.103149","volume":"71","author":"W Sun","year":"2023","unstructured":"Sun W, Wang P, Gong J, Chen Y, Yang Y, Luan H et al (2023) Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation. Stem cell Res 71:103149","journal-title":"Stem cell Res"},{"issue":"7","key":"950_CR24","doi-asserted-by":"publisher","first-page":"167925","DOI":"10.1016\/j.bbadis.2025.167925","volume":"1871","author":"H Latifi-Navid","year":"2025","unstructured":"Latifi-Navid H, Mokhtari S, Taghizadeh S, Moradi F, Poostforoush-Fard D, Alijanpour S et al (2025) AI-assisted multi-OMICS analysis reveals new markers for the prediction of AD. Biochimica et biophysica acta. Mol basis disease 1871(7):167925","journal-title":"Mol basis disease"},{"issue":"24","key":"950_CR25","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1111\/jcmm.17999","volume":"27","author":"Y Lin","year":"2023","unstructured":"Lin Y, Zhang L, Gao M, Tang Z, Cheng X, Li H et al (2023) miR-6076 targets BCL6 in SH-SY5Y cells to regulate amyloid-\u03b2-induced neuronal damage. J Cell Mol Med 27(24):4145\u20134154","journal-title":"J Cell Mol Med"},{"issue":"21","key":"950_CR26","first-page":"2309","volume":"20","author":"J Qu","year":"2021","unstructured":"Qu J, Xiong X, Hujie G, Ren J, Yan L, Ma L (2021) MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer\u2019s disease by downregulation of HNRNPU stabilized BACE1. Cell cycle (Georgetown. Tex) 20(21):2309\u20132320","journal-title":"Tex)"},{"key":"950_CR27","doi-asserted-by":"publisher","first-page":"153331752110205","DOI":"10.1177\/15333175211020572","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shi M, Hong Z, Kang J, Pan H, Yan C (2021) MiR-130a-3p has protective effects in Alzheimer\u2019s disease via targeting DAPK1. Am J Alzheimer\u2019s Dis Other Dementias 36:15333175211020572","journal-title":"Am J Alzheimer\u2019s Dis Other Dementias"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00950-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:08:12Z","timestamp":1792231692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00950-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s10048-026-00950-y","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by The Ethics Committee of Shantou Central Hospital (Approval Number: (2020)-keyan No. 122). All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration and later versions. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"82"}}